MTHFD2 and breast carcinoma: Increasing evidence suggests that MTHFD2 is overexpressed and predicts poor prognosis and promotes cancer cell proliferation and metastasis in certain types of malignancies, including colorectal cancer [29], breast cancer [8], and head and neck squamous cell cancer [8, 25].